GNMLF (Genomma Lab InternacionalB de CV) E10: $0.06 (As of Mar. 2026)


GNMLF Genomma Lab Internacional SAB de CV GNMLF
57 GF Score
Price $0.84
GF Value $0.99
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Genomma Lab InternacionalB de CV E10?

Genomma Lab InternacionalB de CV GNMLF 57 E10 is $0.06 as of Mar. 2026. GuruFocus rates GNMLF with a GF Score™ of 57/100 and a GF Value™ of $0.99 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Genomma Lab InternacionalB de CV's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.028. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.06 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Genomma Lab InternacionalB de CV's average E10 Growth Rate was 40.70% per year. During the past 3 years, the average E10 Growth Rate was 7.80% per year. During the past 5 years, the average E10 Growth Rate was 1.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Genomma Lab InternacionalB de CV was 7.80% per year. The lowest was -5.40% per year. And the median was 0.40% per year.

As of today (2026-06-30), Genomma Lab InternacionalB de CV's current stock price is $0.8368. Genomma Lab InternacionalB de CV's E10 for the quarter that ended in Mar. 2026 was $0.06. Genomma Lab InternacionalB de CV's Shiller PE Ratio of today is 13.95.

During the past 13 years, the highest Shiller PE Ratio of Genomma Lab InternacionalB de CV was 36.88. The lowest was 12.82. And the median was 20.09.


Genomma Lab InternacionalB de CV  (OTCPK:GNMLF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Genomma Lab InternacionalB de CV's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.8368/0.06
=13.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Genomma Lab InternacionalB de CV was 36.88. The lowest was 12.82. And the median was 20.09.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Genomma Lab InternacionalB de CV E10 Related Terms


Genomma Lab InternacionalB de CV E10 Historical Data

* Premium members only.

The historical data trend for Genomma Lab InternacionalB de CV's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomma Lab InternacionalB de CV E10 Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.05 0.05 0.04 0.07

Genomma Lab InternacionalB de CV Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.04 0.05 0.07 0.06

GNMLF vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's Shiller PE Ratio falls into.


GNMLF
57GF Score
Genomma Lab Internacional SAB de CV GNMLF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomma Lab InternacionalB de CV E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genomma Lab InternacionalB de CV's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.028/163.8112*163.8112
=0.028

Current CPI (Mar. 2026) = 163.8112.

Genomma Lab InternacionalB de CV Quarterly Data

per share eps CPI Adj_EPS
201606 -0.131 101.905 -0.211
201609 0.024 103.084 0.038
201612 0.001 105.002 0.002
201703 0.022 108.063 0.033
201706 0.014 108.339 0.021
201709 0.012 109.628 0.018
201712 0.016 112.114 0.023
201803 0.020 113.505 0.029
201806 0.015 113.373 0.022
201809 0.011 115.130 0.016
201812 0.010 117.530 0.014
201903 0.012 118.050 0.017
201906 0.012 117.848 0.017
201909 0.011 118.581 0.015
201912 0.001 120.854 0.001
202003 0.016 121.885 0.022
202006 0.015 121.777 0.020
202009 0.018 123.341 0.024
202012 0.013 124.661 0.017
202103 0.015 127.574 0.019
202106 0.019 128.936 0.024
202109 0.019 130.742 0.024
202112 0.010 133.830 0.012
202203 0.017 137.082 0.020
202206 0.020 139.233 0.024
202209 0.020 142.116 0.023
202212 0.013 144.291 0.015
202303 0.019 146.472 0.021
202306 0.025 146.272 0.028
202309 0.021 148.446 0.023
202312 -0.004 151.017 -0.004
202403 0.024 152.947 0.026
202406 0.036 153.551 0.038
202409 0.035 155.246 0.037
202412 -0.008 157.378 -0.008
202503 0.025 158.761 0.026
202506 0.019 160.180 0.019
202509 0.024 161.084 0.024
202512 0.018 163.188 0.018
202603 0.028 163.811 0.028

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.06 mean?
Genomma Lab InternacionalB de CV (GNMLF) has a E10 of $0.06 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Genomma Lab InternacionalB de CV and its competitors.
Is Genomma Lab InternacionalB de CV's E10 too high?
Genomma Lab InternacionalB de CV's current E10 is $0.06. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 57/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's E10 compare to ZTS and UTHR?
Genomma Lab InternacionalB de CV's E10 of $0.06 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Genomma Lab InternacionalB de CV and its competitors. Genomma Lab InternacionalB de CV's current E10 is $0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (GNMLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.99, compared to a current price of $0.84 — trading 15.5% below its estimated fair value. The current E10 is $0.06. Genomma Lab InternacionalB de CV's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (GNMLF), the current E10 is $0.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomma Lab InternacionalB de CV (GNMLF) Overvalued in 2026?

Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued. The current stock price of $0.84 is trading 15.5% below its estimated GF Value™ of $0.99. GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.

Key valuation signals for GNMLF:

  • E10: $0.06
  • GF Value™: $0.99 vs. price of $0.84 (15.5% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the GNMLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genomma Lab InternacionalB de CV Business Description

Other Exchanges LABB:MexicoGEKA:Germany
Address Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
57GF Score

Get the complete analysis for GNMLF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.84
Price
$0.99
GF Value